Katja Buhrer
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Katja Buhrer
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Subsidiary | Pharmaceuticals: Major | 16 | |
11
| Public Company | Pharmaceuticals: Major | 11 |
MBS Value Partners, Inc.
MBS Value Partners, Inc. Investment ManagersFinance MBS Value Partners, Inc. is an investor relations and financial communications advisory company. The private company is based in New York, NY and has subsidiaries in the United States and Brazil. The company was founded by Lynn Morgen and Margaret Mager has been the CEO of the company since 2015.
5
| Private Company | Investment Managers | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Katja Buhrer
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The California State University | College/University | Graduate Degree Undergraduate Degree | |
ALZA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Balance Therapeutics, Inc.
Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Biotechnology | Director/Board Member Founder | |
Media Arts Group, Inc.
Media Arts Group, Inc. Home FurnishingsConsumer Durables Media Arts Group, Inc. designs, manufactures, and markets artistic products based on the works of artist Thomas Kinkade. The company is headquartered in San Jose, CA. | Home Furnishings | Director of Finance/CFO | |
Keller Graduate School of Management | College/University | Masters Business Admin | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of Sheffield | College/University | Undergraduate Degree | |
Petra Pharma Corp.
Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Revelle College | College/University | Undergraduate Degree | |
SD Scientific, Inc. | Chief Executive Officer | ||
Novartis Animal Health US, Inc.
Novartis Animal Health US, Inc. Pharmaceuticals: MajorHealth Technology Part of Elanco Animal Health, Inc., Novartis Animal Health US, Inc. manufactures pharmaceutical products for animals. The company is based in Greensboro, NC. | Pharmaceuticals: Major | Sales & Marketing | |
La Jolla Playhouse, Inc.
La Jolla Playhouse, Inc. Miscellaneous Commercial ServicesCommercial Services La Jolla Playhouse, Inc. provides educational opportunities for children, teens, and adults interested in theatre arts. The company was founded by Gregory Peck, Dorothy McGuire, and Mel Ferrer in 1947 and is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Scripps Clinic & Research Foundation | Corporate Officer/Principal | ||
DTx Pharma, Inc.
DTx Pharma, Inc. Pharmaceuticals: MajorHealth Technology DTx Pharma, Inc. engages in the provision of biotechnology solutions. It focuses on the utilization of fatty acids to enable the delivery of RNA therapeutics to tissues and organ systems beyond the liver. The company was founded by Arthur T. Suckow, John Grundy, and Adam Pavlicek in August 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
Hilltop Biosciences, Inc.
Hilltop Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hilltop Biosciences, Inc. operates as a biotech company that develops room temperature allograft therapies for veterinary applications. It offers ophthalmic, orthopedic, wounds and surgical products. The company was founded by Amanda Drobnis and is headquartered in Norton, MA. | Pharmaceuticals: Major | Director/Board Member | |
AGILE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Harvard Medical School | College/University | Doctorate Degree | |
MYRIAD GENETICS, INC. | Medical Specialties | Corporate Officer/Principal | |
ABBOTT LABORATORIES | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Vrije Universiteit Amsterdam | College/University | Graduate Degree | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman | |
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chairman | |
LYSOGENE | Miscellaneous Commercial Services | Chairman | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Abcd Ltd. | Director/Board Member | ||
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Chairman | |
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Organon NV
Organon NV Pharmaceuticals: MajorHealth Technology N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Corporate Officer/Principal | |
deVGen NV
deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Corporate Officer/Principal | |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
KEZAR LIFE SCIENCES, INC. | Biotechnology | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Roche Netherlands BV
Roche Netherlands BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Netherlands BV is a Dutch company that wholesales pharmaceuticals and diagnostics products. The company is based in Woerden, Netherlands. | Medical Distributors | Sales & Marketing | |
Pierre Fabre Médicament SAS
Pierre Fabre Médicament SAS Pharmaceuticals: OtherHealth Technology Pierre Fabre Médicament SA manufactures cosmetics and pharmaceutical products. It focuses on research, development, and prescription of medicines and cosmetics. The company was founded on December 31, 1982 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
Université Claude Bernard Lyon 1 | College/University | Doctorate Degree | |
École Supérieure de Physique et de Chimie de Paris | College/University | Undergraduate Degree | |
Novartis Groupe France SA
Novartis Groupe France SA Financial ConglomeratesFinance Novartis Groupe France SA is a pharmaceutical company. It provides cure for diseases. The company is headquartered in Rueil-Malmaison, France. | Financial Conglomerates | Corporate Officer/Principal | |
Medichem SA
Medichem SA Pharmaceuticals: MajorHealth Technology Medichem SA is a vertically Spanish integrated pharmaceutical company that specializes in the development and manufacture of APIs and FDFs for the generics market. The company is based in Sant Joan Despi, Spain, and has subsidiaries in Spain. The company offers highly potent active pharmaceutical ingredients (HPAPI) manufacturing, from development to cGMP production, and have an R & D laboratory and GMP kilo-lab. Medichem offers specific chlorhexidine transparent aqueous and alcoholic solutions based on chlorhexidine digluconate as an active ingredient, with a wide range of applications such as pharma, biocide, oral care, cosmetics, and veterinary. The company's chlorhexidine wipes are used for general disinfection. The company was founded in 1972, and José Luis Rodríguez has been the CEO of the company since 1996. | Pharmaceuticals: Major | Chief Executive Officer | |
University of British Columbia | College/University | Undergraduate Degree | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 26 |
Frankreich | 7 |
Schweiz | 6 |
Vereinigtes Königreich | 5 |
Spanien | 5 |
Sektoral
Health Technology | 29 |
Consumer Services | 10 |
Commercial Services | 4 |
Finance | 3 |
Consumer Durables | 2 |
Operativ
Director/Board Member | 89 |
Corporate Officer/Principal | 46 |
Independent Dir/Board Member | 37 |
Chief Executive Officer | 22 |
Chairman | 21 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Ernest Mario | 44 |
Joseph McCracken | 20 |
Frank Verwiel | 16 |
Elizabeth Garner | 15 |
Nanxi Liu | 11 |
Herbert D. Montgomery | 10 |
Annette Clancy | 10 |
Ervin Veszprémi | 9 |
Margaret Mager | 8 |
Ben T. G. Tan | 8 |
Clive Bertram | 8 |
Denise Bevers | 8 |
Raymond Townsend | 7 |
William Brown | 7 |
Luigi Marro | 7 |
- Börse
- Insiders
- Katja Buhrer
- Unternehmensverbindungen